Literature DB >> 16809330

Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication.

Ramtin Rahbar1, Thomas T Murooka, Anna A Hinek, Carole L Galligan, Antonella Sassano, Celeste Yu, Kishore Srivastava, Leonidas C Platanias, Eleanor N Fish.   

Abstract

Vaccinia virus, a poxvirus, produces structurally distinct forms of virions for which the immediate events following cell entry are ill-defined. We provide evidence that intracellular mature virus (IMV) enters both permissive and nonpermissive T-cell lines and that introduction of CCR5 into nonpermissive mouse fibroblasts or human primary T cells renders the cells permissive for vaccinia replication. Notably, T cells expressing CCR5 in which tyrosine 339 in the intracellular region is replaced by phenylalanine no longer support virus replication or virus-inducible activation of specific host cell signaling effectors IRS-2, Grb2, and Erk1/2. We show that following IMV entry into the cell, the intact but not the tyrosine-deficient CCR5 is rapidly internalized and colocalizes with virus. This colocalization precedes virus-inducible signaling and replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809330      PMCID: PMC1489052          DOI: 10.1128/JVI.00463-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  Viral exploitation and subversion of the immune system through chemokine mimicry.

Authors:  P M Murphy
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  Chemokine receptor dimerization: two are better than one.

Authors:  J M Rodríguez-Frade; M Mellado; C Martínez-A
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

3.  Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus.

Authors:  Niki Scaplehorn; Anna Holmström; Violaine Moreau; Freddy Frischknecht; Inge Reckmann; Michael Way
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

4.  Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells.

Authors:  M Wong; S Uddin; B Majchrzak; T Huynh; A E Proudfoot; L C Platanias; E N Fish
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

Review 5.  Viral chemokine-binding proteins.

Authors:  Bruce T Seet; Grant McFadden
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

6.  Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.

Authors:  S Li; A D Couvillon; B B Brasher; R A Van Etten
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

7.  Poxvirus infection rapidly activates tyrosine kinase signal transduction.

Authors:  J Masters; A A Hinek; S Uddin; L C Platanias; W Zeng; G McFadden; E N Fish
Journal:  J Biol Chem       Date:  2001-10-08       Impact factor: 5.157

8.  A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication.

Authors:  J C de Magalhães; A A Andrade; P N Silva; L P Sousa; C Ropert; P C Ferreira; E G Kroon; R T Gazzinelli; C A Bonjardim
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

9.  A critical role for IL-12 in CCR5 induction on T cell receptor-triggered mouse CD4(+) and CD8(+) T cells.

Authors:  M Iwasaki; T Mukai; P Gao; W R Park; C Nakajima; M Tomura; H Fujiwara; T Hamaoka
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

10.  A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression.

Authors:  S Venkatesan; A Petrovic; M Locati; Y O Kim; D Weissman; P M Murphy
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

View more
  19 in total

1.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells.

Authors:  Shu-Jung Chang; Yu-Xun Chang; Roza Izmailyan; Yin-Liang Tang; Wen Chang
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

3.  Role for CCR5 in dissemination of vaccinia virus in vivo.

Authors:  Ramtin Rahbar; Thomas T Murooka; Eleanor N Fish
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

4.  A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis.

Authors:  Cheng-Yen Huang; Tsai-Yi Lu; Chi-Horng Bair; Yuan-Shau Chang; Jeng-Kuan Jwo; Wen Chang
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

5.  Intracellular Transport of Vaccinia Virus in HeLa Cells Requires WASH-VPEF/FAM21-Retromer Complexes and Recycling Molecules Rab11 and Rab22.

Authors:  Jye-Chian Hsiao; Li-Wei Chu; Yung-Tsun Lo; Sue-Ping Lee; Tzu-Jung Chen; Cheng-Yen Huang; Yueh-Hsin Ping; Wen Chang
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

6.  The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis.

Authors:  Nina Schroeder; Che-Sheng Chung; Chein-Hung Chen; Chung-Lin Liao; Wen Chang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

7.  Chemokine binding protein vCCI attenuates vaccinia virus without affecting the cellular response elicited by immunization with a recombinant vaccinia vector carrying the HPV16 E7 gene.

Authors:  Pavel Gabriel; Katarina Babiarova; Kamila Zurkova; Jitka Krystofova; Petr Hainz; Luda Kutinova; Sarka Nemeckova
Journal:  Viral Immunol       Date:  2012-10       Impact factor: 2.257

8.  Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus.

Authors:  Raymond S Weinstein; Michael M Weinstein; Kenneth Alibek; Michael I Bukrinsky; Beda Brichacek
Journal:  BMC Immunol       Date:  2010-05-18       Impact factor: 3.615

9.  Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo.

Authors:  Christophe Vanpouille; Angélique Biancotto; Andrea Lisco; Beda Brichacek
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

10.  Vaccinia virus encodes I5, a small hydrophobic virion membrane protein that enhances replication and virulence in mice.

Authors:  Cindy L Sood; Jerrold M Ward; Bernard Moss
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.